Announcing the second edition of Appetite for Success, Jack Payne’s Definitive Guide to Maximizing Technology in the Food and Beverage Industry; Sponsored by Aptean, the new edition expands the playbook for leaders navigating the AI era scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study
Reduced average 30-day heart failure related costs by $17,753 (p<0.0001) per study subject in FUROSCIX®…
Berkeley Lights to Report Second Quarter 2021 Financial Results on August 11, 2021
EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader…
Seer to Report Second Quarter Financial Results on August 12, 2021
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
Zealand Pharma A/S – Transaction Under Share Repurchase Program
Company announcement – No. 46 / 2021 Zealand Pharma A/S – Transaction Under Share Repurchase…
Imara Announces Launch of Proposed Public Offering
BOSTON, July 13, 2021 (GLOBE NEWSWIRE) — Imara Inc. (the “Company”) (Nasdaq: IMRA), a clinical-stage…
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
Initiated Phase 1 trial of lead program NX-2127 in patients with relapsed or refractory B-cell…
CBD Trailblazer Turns CBD Users Into Investors
Nordic Oil, a market leader in the European CBD industry, has launched its first ever…
Groundbreaking Study Establishes Non-Surgical Treatment Modality to Improve Function in Children With Cerebral Palsy
SpineX’s Proprietary SCONE™ Device Offers New Hope to Families of Children with CP SCONE Device…
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function…
Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO
Infant Bacterial Therapeutics AB (publ) today announced that Marie-Louise Alamaa has been appointed Chief Financial…
Lixte Biotechnology Comments on Outside Research Citing LB-100’s PP2A Inhibition as a Potential Therapeutic Strategy for Triple-Negative Breast Cancer
Altadena, CA, July 13, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“Lixte”…
Ocuphire Selected to Present at Multiple Ophthalmic Conferences in July
Positive Results from Phase 2 Presbyopia (VEGA-1) and Phase 3 Reversal of Mydriasis (MIRA-2) Studies…
Yield10 Bioscience Begins 2021 Field Test and Seed Scale Up Program
WOBURN, Mass., July 13, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide
OSTEOAMP SELECT Flowable from Bioventus A demonstration of how OSTEOAMP SELECT Flowable can be easily…
Vallon Pharmaceuticals Announces Issuance of New European Patent Covering Method of Use and Composition of Matter for ADAIR
– Patent bolsters intellectual property protection as Company’s partner, MEDICE, works to develop and potentially…
ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
MONTREAL, July 13, 2021 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), a clinical-stage molecular medicine company…
TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder
Inhaled Tacrolimus Powder Achieves Systemic Therapeutic Drug Levels Anticipate Additional Safety Data in 3Q 2021 Initiation of…
Certara Announces New Chief Human Resources Officer
Veteran HR leader brings 20+ years of human resources experience to the company’s executive team…
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. rNAPc2 development focused on…
Nautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
SEATTLE, July 13, 2021 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…